Comment Period Extended for Genetically Engineered Salmon

The FDA has extended the comment period for two draft environmental review documents on the proposed conditions of a new animal drug application (NADA) concerning genetically engineered Atlantic salmon.

The comment extension is for interested persons to have additional tome to respond to the NADA on genetically engineered (GE) Atlantic salmon. Individuals can submit their electronic or written comments by April 26, 2013. Electronic comments can be submitted here.

For those sending written comments, please send to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Identify comments with the docket number found in brackets in the heading of this document.

Featured Webinar